Clinical Trial Update: Early Detection of Neuropathy in ATTRv

View source ↗

Summary

A University of Pennsylvania-sponsored clinical trial on early detection of neuropathy in hereditary transthyretin-mediated amyloidosis (ATTRv) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Transthyretin-mediated Amyloidosis

Snippet

Sponsor: University of Pennsylvania | Conditions: Hereditary Amyloidosis, Transthyretin-Related | Status: COMPLETED